Intrinsic Imaging has received a contract to conduct a four-year, multinational Phase II study of metastatic breast cancer. The company will provide imaging services, including disease staging through PET/CT and nuclear imaging, and will facilitate the collection, exchange and processing of medical images from more than 60 trial sites in 10 countries.

Full Story:

Related Summaries